B3 GEL
Live / Applied — Statement of use — processing complete, to examiner (as of 06 Mar 2026)
What this means for you
Not registered yet, but its 26 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98420352
- Mark type
- Stylized text
- Filed
- 26 Feb 2024
- Published for opposition
- 14 Jan 2025
- Attorney of record
- Emily M. Haas
Goods and services
- Class 005 — Pharmaceuticals: Hydrogel for medical purposes
- Class 010 — Medical apparatus: Artificial biomaterials for augmentation of bone and tissue for medical purposes; Coatings sold as an integral component of medical stents and other implantable medical devices
Owner
- TYBR Health, Inc., Houston, TX, US
- TYBR Health, Inc., Houston, TX, US
Prosecution history
- 06 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Aug 2025 — USE AMENDMENT FILED
- 05 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 11 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jan 2025 — PUBLISHED FOR OPPOSITION
- 08 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Nov 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Nov 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Nov 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Nov 2024 — NON-FINAL ACTION E-MAILED
- 19 Nov 2024 — NON-FINAL ACTION WRITTEN